Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life
Journal of the Endocrine Society · 08.07.2025 · 9 (9)
DOI: 10.1210/jendso/bvaf106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 18.06.2025. Verfasst von Nicole Turk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Diabetes Association.
Abstract (Originalsprache)
Context
Postbariatric hypoglycemia (PBH), complicating up to one-third of bariatric surgeries, is characterized by repeated episodes of severe hypoglycemia and hypoglycemia unawareness that threaten patient safety and impair quality of life.
Objective
We tested the hypothesis that use of a continuous glucose monitor (CGM) would reduce hypoglycemia and improve quality of life in patients with PBH.
Design
In a crossover design, 14 patients with diagnosed PBH were assigned in random order to sequential treatment with unblinded CGM or blinded CGM/no alarms for 10 days each. Glucose and quality of life measures were compared between the 2 periods.
Setting
Outpatient. Outcomes Hypoglycemia measured by fingerstick blood glucose in response to symptoms or CGM alarm and CGM glucose values; quality of life measures included dietary liberalization and hypoglycemia-related worries/behaviors captured by the Hypoglycemia Fear Survey-II.
Results
Baseline frequency of hypoglycemic events, disability, and hypoglycemia-related worries were high. Symptom-triggered hypoglycemic events confirmed by fingerstick glucose were reduced 6-fold (P = .008) and the glucose nadir measured by CGM was >8 mg/dL higher (P = .005) during unblinded use of CGM compared to the blinded comparison period. Hypoglycemia Fear Survey-II scores improved significantly in response to unblinded CGM use compared to the blinded control period (P = .026). The intake of carbohydrate-containing meals increased without increasing rate of postprandial hyper- or hypoglycemia.
Conclusion
Use of unblinded CGM in patients with PBH reduces frequency and severity of hypoglycemia and improves quality of life by decreasing hypoglycemia-related worries and enabling a less restrictive diet. CGM should be considered a first-line treatment for patients with PBH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
ORCID-Profile: Nicole Turk, Tracey McLaughlin
Förderung
- American Diabetes Association
Zitieren
APA
Turk, N., Ramanujan, S., Shamloo, T., Craig, C., & McLaughlin, T. (2025). Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life. Journal of the Endocrine Society, 9(9). https://doi.org/10.1210/jendso/bvaf106
Vancouver
Turk N, Ramanujan S, Shamloo T, Craig C, McLaughlin T. Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life. Journal of the Endocrine Society. 2025;9(9). doi:10.1210/jendso/bvaf106
BibTeX
@article{Turk2025,
author = {Turk, Nicole and Ramanujan, Suruchi and Shamloo, Termeh and Craig, Colleen and McLaughlin, Tracey},
title = {Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life},
journal = {Journal of the Endocrine Society},
year = {2025},
volume = {9},
number = {9},
doi = {10.1210/jendso/bvaf106}
}
EUVIMED